Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.33 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21073933 | 0.89 | KDM4E (0.37) | TAS1R3TAS1R1IMPDH2 | |
| SCHEMBL20214768 | 0.87 | TAS1R3 (0.35) | TAS1R3TAS1R1DNPH1IMPDH2 | |
| SCHEMBL20214610 | 0.86 | DNPH1 (0.35) | TAS1R3TAS1R1DNPH1IMPDH2 | |
| SCHEMBL25495905 | 0.79 | KDM4E (0.38) | TAS1R3TAS1R1IMPDH2 | |
| SCHEMBL27104319 | 0.79 | KDM4E (0.38) | TAS1R3TAS1R1IMPDH2 | |
| SCHEMBL21073930 | 0.78 | KDM4E (0.38) | TAS1R3TAS1R1IMPDH2 | |
| SCHEMBL19762769 | 0.77 | KDM4E (0.38) | TAS1R3TAS1R1DNPH1 | |
| SCHEMBL17317469 | 0.77 | TAS1R3 (0.36) | TAS1R3TAS1R1IMPDH2 | |
| SCHEMBL21073932 | 0.77 | KDM4E (0.38) | TAS1R3TAS1R1DNPH1IMPDH2 | |
| SCHEMBL23350797 | 0.76 | KDM4E (0.45) | TAS1R3TAS1R1IMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512861-A2 | CYCLIC DINUCLEOTIDES AS STING (STIMULATOR OF INTEFERON GENES) AGONISTS | Takeda Pharmaceutical Company Limited (JP) | 2019-07-24 | — | — | EP | disclosed |
| WO-2018100558-A2 | CYCLIC DINUCLEOTIDE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-06-07 | — | — | WO | disclosed |